GLP Watchdog

Best Tirzepatide for PCOS in 2026: Ranked and Reviewed

Insulin resistance sits underneath much of polycystic ovary syndrome, which is the reason clinicians reach for a GLP-1 here. The trial record is thinner than the enthusiasm: eleven randomized trials in all, and the most careful review of them rates the weight effect low-certainty and the evidence on periods insufficient. There is no PCOS indication behind any of it. Tirzepatide is prescribed off-label here, sometimes alongside metformin and sometimes in place of it, and off-label prescribing is legal when a licensed clinician judges it appropriate. The table below scores sellers on price, disclosure and licensure. It cannot tell you whether a given clinic treats PCOS as a reason to prescribe, so raise it during intake.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

598 tirzepatide providers compared · independently scored against our six-factor methodology.

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Methodology & sources

Each provider here carries a score from our published six-factor rubric[1], and the list is then cut down to the criteria named in the page title.

Published Phase 3 efficacy for tirzepatide (~20.9% mean weight loss at the 15 mg dose over 72 weeks) comes from the SURMOUNT-1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].

Quick Picks

Starting price per provider. Prices in USD per month; checked November 2026.
#ProviderScore
1EmbodyVisit
2SnagRxVisit
3CollectiveVisit
4CoreAge RxVisit
5LttlVisit

What the trials show in PCOS

The PCOS evidence is small and it disagrees with itself. These are the figures our PCOS review reports, from the reviews it weighs against each other.

  • 11 RCTs

    the whole randomized evidence base in PCOS

    A registered 2026 systematic review in the European Journal of Endocrinology found 11 randomized trials of GLP-1 drugs in women with PCOS. As an add-on, BMI fell by 1.38 points, graded low-certainty. On glucose, insulin, hirsutism and menstrual regularity the evidence was insufficient to conclude anything, and no trial measured quality of life.[4]

    What the newest review found →

  • 1.72x

    natural pregnancy rate in one 2023 meta-analysis

    A 2023 meta-analysis of 840 women in BMC Endocrine Disorders read the same question more positively: a natural pregnancy rate 1.72 times that of controls (95% CI 1.22 to 2.43), with better menstrual cyclicity. The registered 2026 review is the more cautious of the two, and it is the one that graded its certainty.[5]

  • SMD -0.40

    insulin sensitivity, GLP-1 against metformin

    In a 2019 meta-analysis of 8 trials comparing the two directly, insulin sensitivity improved more on a GLP-1 (standardized mean difference -0.40, 95% CI -0.74 to -0.06) and BMI fell further. Nausea and headache were more common on the GLP-1, and nothing else measured differed.[6]

  • No interval

    named on either tirzepatide label before a planned pregnancy

    Many women with PCOS take a GLP-1 hoping to conceive. The semaglutide labels want two months or more without the drug first; the tirzepatide labels name no interval at all. That silence is not permission, so set the gap with the prescriber before the first dose.[7]

    Preconception timing, drug by drug →

Detailed Reviews

1

Embody

Verified partner

Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

9.3

Embody is the brand Modern Metabolic Medicine, Inc. runs through its JoinEm storefront. It sells compounded semaglutide and tirzepatide injections at one price per drug at every dose, $79 and $129 for a one-month supply, plus a compounded oral tirzepatide gum. You pay at checkout, before an OpenLoop Health clinician decides on a prescription, and payments are final.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
10
Support10%
7
Starting from $129/moRead full review →
Visit Embody →
2

SnagRx

Verified partner

Best for: semaglutide at $99/month, well below the typical price

9.2

SnagRx sells compounded semaglutide at $99 a month and compounded tirzepatide at $149 a month on its 1-month plan, one price at every dose. Longer plans cut the monthly rate but are charged in full up front and are non-refundable. Clinicians come from the OpenLoop Health network; the platform is Modern Metabolic Medicine, Inc. The visit and 1-2 day shipping are included, with no insurance and no membership.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
9.8
Support10%
7
Starting from $149/moRead full review →
Visit SnagRx →
3

Collective

Verified partner

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

9.1

Health For Everyone Inc., trading as CollectiveOS, sells compounded semaglutide at $59/mo and compounded tirzepatide at $69/mo on a membership model, with a mandatory $199 annual membership on top that the headline price does not include. It prices every dose the same, so the cost does not climb as the dose is titrated, and it does not require prepaying for medication. The site is marketed as being from the founder of Thrive Market. Neither its pharmacies nor its medical groups are named.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
9
Support10%
7
Starting from $69/moRead full review →
Visit Collective →
4

CoreAge Rx

Verified partner

Best for: flat-priced compounded semaglutide at $79 a month, any dose

9.0

CoreAge Rx charges the same amount at every dose of its compounded GLP-1s: semaglutide is $79 a month, tirzepatide $129. Consult and shipping are inside that figure, and there is no membership fee. You pay before a doctor reviews the case, and every prescription sale is final once it reaches the pharmacy.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
9.7
Support10%
7
Starting from $129/moRead full review →
Visit CoreAge Rx →
5

Lttl

Verified partner

Best for: starting below a standard dose, with microdose tiers

9.0

Lttl sells compounded semaglutide at $99 a month and tirzepatide at $149 a month on its month-to-month plan, one flat price at any dose. Prepaying for 12 months lowers those to $89 and $139. Every price and commitment length is on a public plans page before checkout. A microdose line at $149 a month and longevity peptides fill out the catalog.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
10
Support10%
7
Starting from $149/moRead full review →
Visit Lttl →
6

YourEra

Verified partner

Best for: semaglutide at $99/month, well below the typical price

9.0

YourEra sells compounded semaglutide and compounded tirzepatide injections through an online visit with a licensed clinician, at one price for every dose. It is run by Your Era Management, L.L.C. in Louisiana, and it names its medical group and its three pharmacies. Semaglutide is $99 a month month-to-month. Tirzepatide is published only as a 12-month prepaid plan averaging $99 a month.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
10
Support10%
7
Starting from $99/moRead full review →
Visit YourEra →
7

altRX

Verified partner

Best for: compounded semaglutide from $89/month at the same price at every dose

8.8

Compounded plans open at $89 for semaglutide and $149 for tirzepatide, the same at every dose. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer. FDA sent its operator a warning letter in June 2026.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
6
Accessibility10%
10
Support10%
7
Starting from $149/moRead full review →
Visit altRX →
8

Eden

Verified partner

Best for: coverage in all 50 states, which most sellers will not confirm

8.7

Eden sells compounded semaglutide and tirzepatide through its own pharmacy network and a contracted provider group. Its price pages promise the same charge at every dose and say there is no membership fee. Its own terms still describe a $39-then-$99 monthly membership with medication billed on top. Semaglutide is $99 a month and tirzepatide $129.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
4.5
Accessibility10%
10
Support10%
8.5
Starting from $129/moRead full review →
Visit Eden →
9

Strut Health

Verified partner

Best for: semaglutide at $99/month, well below the typical price

8.6

Strut Health sells LegitScript and ACHC-accredited compounded semaglutide and tirzepatide in injectable and oral lozenge formats, shipping to 49 states. Board-certified US physicians handle prescribing and follow-up messaging is unlimited and free. Eligibility is gated behind a clinician determination of medical necessity that the company does not publicly define.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
4.5
Accessibility10%
9.8
Support10%
7
Starting from $149/moRead full review →
Visit Strut Health →
10

Gala

Verified partner

Best for: moving between compounded and brand without changing seller

8.5

A yearly plan is the format: compounded semaglutide and compounded tirzepatide are sold that way, with brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware; care comes through OpenLoop-affiliated medical groups. Compounded GLP-1 is $179 a month on the yearly plan, all doses included. A Wegovy pill taken orally is flagged as coming soon.

Score Breakdown

Value25%
7.9
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
7.5
Accessibility10%
10
Support10%
7
Starting from $179/moRead full review →
Visit Gala →

Ranked 11 to 30

The same ranking continues in short form: each seller's score, the lowest standing price we hold, and a link to its full review.

  1. 11
    bmiMDVerified partner

    From $179/mo

    8.2
  2. 12
    HealthRXVerified partner

    From $214/mo

    8.2
  3. 13
    Live VitalVerified partner

    From $239/mo

    8.2
  4. 14
    Sesame CareVerified partner

    From $299/mo

    8.1
  5. 15
    PlexusDxVerified partner

    From $99/mo

    8.0
  6. 16
    Sprout HealthVerified partner

    From $149/mo

    8.0
  7. 17
    Belle HealthVerified partner

    From $249/mo

    7.9
  8. 18
    Luvo HealthVerified partner

    From $179/mo

    7.9
  9. 19
    RxSpan MDVerified partner

    From $329/mo

    7.9
  10. 20
    ShedRxVerified partner

    From $299/mo

    7.9
  11. 21
    AgelessRxVerified partner

    From $209/mo

    7.4
  12. 22
    WellorithmVerified partner

    From $349/mo

    7.4
  13. 23
    FoundVerified partner

    From $299/mo

    7.3
  14. 24
    Ivim HealthVerified partner

    From $192/mo

    7.3
  15. 25
    MEDGmVerified partner

    From $269/mo

    7.3
  16. 26
    OakVerified partner

    From $300/mo

    7.2
  17. 27
    Direct MedsVerified partner

    From $299/mo

    7.1
  18. 28
    DudeMedsVerified partner

    From $233/mo

    6.8
  19. 29
    GoodLife HealthVerified partner

    From —

    6.8
  20. 30
    HumeCare+Verified partner

    From $299/mo

    6.6

568 more sellers we track for this

Ranked below the 30 above on the same rubric. Each links to its full review with current pricing.

← See all Tirzepatide Providers

PCOS-specific research

We rank the list above the same way for every reader. What differs for pcos is the clinical context, and these evidence reviews go into it:

Frequently Asked Questions

No. There is no FDA approval for PCOS. The approvals cover chronic weight management and type 2 diabetes, and PCOS use is off-label, aimed at the insulin resistance underneath the syndrome and the weight loss that follows from treating it. Off-label prescribing is legal and routine. It also means no label tells your clinician how to dose specifically for PCOS.
They are not interchangeable, and they are often combined. In a 2019 meta-analysis of 8 trials that compared the two directly, insulin sensitivity and BMI both improved more on a GLP-1, while nausea and headache were more common, and the authors called the overall evidence inconclusive. Which suits you is a clinical judgment, and cost sits on the other side of it, with a wide gap between the two.
Possibly, indirectly, and not while you are taking it. Weight loss restores more regular ovulation for some women with PCOS, and one 2023 meta-analysis reported a higher natural pregnancy rate, though a more careful 2026 review found the evidence on periods too thin to conclude. Neither tirzepatide label names a waiting period before a planned pregnancy, so the gap between the last dose and trying is one to set with your prescriber. It works as preparation rather than treatment, so fix the timing before you start, not after.
Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
  4. 4.GLP-1 receptor agonist treatment in women with polycystic ovary syndrome: a systematic review and meta-analysis (Forslund M et al.)— European Journal of Endocrinology.PMID: 41701618.
  5. 5.Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review (Zhou L et al.)— BMC Endocrine Disorders.PMID: 37940910.
  6. 6.GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis (Han Y et al.)— Reproductive BioMedicine Online.PMID: 31229399.
  7. 7.Zepbound (tirzepatide) prescribing information, DailyMed SPL— Eli Lilly and Company, via the National Library of Medicine (DailyMed).